L26/P-633 Biop-C: a Hi-C–based approach for PGT-SR enabling detection of balanced and unbalanced chromosomal abnormalities
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.963 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von Y. Stepanchuk und 12 weiteren Autor:innen.
Abstract (Originalsprache)
Study question Can Biop-C distinguish normal embryos from ones carrying balanced and unbalanced chromosomal rearrangements? Summary answer Biop-C detects balanced and unbalanced chromosomal rearrangements, including Robertsonian translocations, in human preimplantation embryos using custom-developed algorithms for CNV and translocation calling. What is known already Balanced chromosomal rearrangements are associated with infertility and pregnancy loss and occur in ∼0.5% of the general population and up to 4% of couples with recurrent miscarriage. Their detection is particularly important for X-autosome translocations, where embryonic phenotype in females is unpredictable due to random or skewed X-chromosome inactivation. Most current PGT-SR strategies based on copy-number profiling detect unbalanced abnormalities but cannot identify balanced carriers. Although breakpoint-targeted methods can address this limitation, they require additional experiments and remain time-consuming and costly. These challenges highlight the need for improved PGT-SR approaches enabling accurate detection of balanced and unbalanced chromosomal rearrangements. Study design, size, duration The study was approved by the local ethics committee of the Institute of Cytology and Genetics (protocol no. 177, 16.12.2022). All participants provided informed consent for embryo donation. Only embryos not eligible for future IVF cycles and classified as unbalanced by standard PGT-A were included. Balanced embryos were donated only when couples had completed their reproductive goals and elected not to retain balanced embryos. Donated embryos were thawed and re-biopsied for Biop-C analysis. Participants/materials, setting, methods The study included 46 couples, 17 carrying known balanced chromosomal rearrangements. Human embryos were cultured for 5–6 days, biopsied, and vitrified. Based on patient consent, embryos were subsequently thawed and re-biopsied. Biopsy material and whole embryos were fixed in 2% paraformaldehyde and analysed using Biop-C, following a modified single-nucleus Hi-C protocol (Gridina et al., 2022). Translocation and CNV calling performed using custom-developed algorithms. Main results and the role of chance We developed Biop-C, a Hi-C–based method enabling detection of unbalanced and balanced chromosomal rearrangements, including Robertsonian translocations, together with copy-number variations (CNVs), in embryo and re-biopsy samples. Custom algorithms enabled accurate translocation calling, and a machine-learning–based approach allowed CNV detection from low-coverage Hi-C data without requiring euploid control embryos. In a cohort of over 100 samples, Biop-C showed concordant ploidy status with standard PGT in 93% of embryos and 76% of re-biopsies. Among 36 samples from carriers of balanced chromosomal rearrangements, Biop-C correctly identified 83% of translocations, including 15 unbalanced and 4 balanced events. In addition, Biop-C detected an unbalanced t(18;21) translocation in an embryo from a couple with a previously undiagnosed parental translocation, 46,XY,t(18;21)(q22.1;q21.3). These findings establish Biop-C as a powerful PGT-SR approach for distinguishing between normal and balanced embryos. Limitations, reasons for caution Biop-C currently does not support SNP calling, detection of uniparental disomy or polyploidy. Wider implications of the findings Biop-C shows strong potential as a PGT-SR approach enabling detection of balanced and unbalanced translocations and CNVs, facilitating distinction between normal and balanced embryos and supporting embryo selection and genetic counseling, particularly for patients with X-autosome or other complex chromosomal rearrangements. Trial registration number No
Zitieren
APA
Stepanchuk, Y., Popov, A., Ivanov, A., Chuyko, E., Kanbekova, O., Saifitdinova, A., Torgunakov, N., Panchenko, D., Zhigalina, D., Skryabin, N., Lebedev, I., Gridina, M., & Fishman, V. (2026). L26/P-633 Biop-C: a Hi-C–based approach for PGT-SR enabling detection of balanced and unbalanced chromosomal abnormalities. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.963
Vancouver
Stepanchuk Y, Popov A, Ivanov A, Chuyko E, Kanbekova O, Saifitdinova A, et al. L26/P-633 Biop-C: a Hi-C–based approach for PGT-SR enabling detection of balanced and unbalanced chromosomal abnormalities. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.963
BibTeX
@article{Stepanchuk2026,
author = {Stepanchuk, Y. and Popov, A. and Ivanov, A. and Chuyko, E. and Kanbekova, O. and Saifitdinova, A. and Torgunakov, N. and Panchenko, D. and Zhigalina, D. and Skryabin, N. and Lebedev, I. and Gridina, M. and Fishman, V.},
title = {L26/P-633 Biop-C: a Hi-C–based approach for PGT-SR enabling detection of balanced and unbalanced chromosomal abnormalities},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.963}
}
EUVIMED